COCHLEAR LIMITED — Regulatory Filings 2014

Jun 1, 2014

==> picture [595 x 56] intentionally omitted <==

==> picture [595 x 56] intentionally omitted <==

ASX/MEDIA RELEASE

2 June 2014

COCHLEAR TO LAUNCH NUCLEUS[®] PROFILE™ IMPLANT SERIES IN EUROPE

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced it will be launching the Cochlear[™] Nucleus[®] Profile[™] Series across Europe in June.

The Cochlear Nucleus Profile implant with the Contour Advance[®] electrode is the first in the Profile Series, which has the thinnest implant body on the market and will be the platform for the company’s next generation of implants.

The Profile with Contour Advance Electrode (CI512) is based on the CI500 Series of implants and has been approved by TÜV Rheinland following extensive work to relocate and build a new production process at Cochlear’s Macquarie University facility.

The introduction further expands what is already the industry’s largest cochlear implant portfolio and supports a wider range of surgical techniques among implanting surgeons, giving them and their patients the greatest possible choice. Other electrodes will be introduced onto the series over the coming months.

The Profile with Contour Advance Electrode will be launched in other countries and regions as regulatory approvals are received.

Ends

Company contact:

Media contact:

Dr Chris Roberts, CEO/President Piers Shervington, Corporate Communications p: + 61 2 9428 6555 P: +61 2 9425 5416